• Mouse Vaspin (Visceral Adipose Tissue Derived Serine Protease Inhibitor) Sandwich ELISA Kit Ready-To-Use (STJE0019360)

Mouse Vaspin (Visceral Adipose Tissue Derived Serine Protease Inhibitor) Sandwich ELISA Kit Ready-To-Use (STJE0019360)

SKU:
STJE0019360

Shipping:
Free Shipping
Current Stock:
Applications: ELISA
Reactivity: Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Sensitivity: 0.053ng/mL
Detection Limit: 0.156-10ng/mL
Short Description: This Vaspin Sandwich ELISA Kit, Ready-To-Use is an in-vitro enzyme-linked immunosorbent assay for the measurement of samples in mouse cell culture supernatant, serum and plasma (EDTA, citrate, heparin).
Storage Instruction: The whole kit may be stored at-20°C for up to 12 months from receipt. An unopened kit may be stored in the fridge at 2-8°C for up to 6 months. Once opened store individual kit contents according to components table provided with the kit.
Assay Time: 3 hrs
Gene Symbol: Serpina12
Gene ID: 68054
Uniprot ID: SPA12_MOUSE
Immunogen Region: Ready-To-Use
Sample Type: serum, plasma, tissue homogenates or other biological fluids.
Tissue Specificity Expressed in visceral adipose tissues.
Post Translational Modifications Glycosylation slightly decreases affinity for heparin, but otherwise has no significant effect on KLK7 inhibitory activity or thermal stability of the protein.
Function Adipokine that modulates insulin action by specifically inhibiting its target protease KLK7 in white adipose tissues.
Protein Name Serpin A12
Visceral Adipose Tissue-Derived Serine Protease Inhibitor
Vaspin
Visceral Adipose-Specific Serpin
Database Links
Cellular Localisation Secreted
Alternative ELISA Names Serpin A12 ELISA kit
Visceral Adipose Tissue-Derived Serine Protease Inhibitor ELISA kit
Vaspin ELISA kit
Visceral Adipose-Specific Serpin ELISA kit
Serpina12 ELISA kit
output

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance